Skip to main content
. 2021 Jun 22;59(5):1715–1726. doi: 10.1007/s13197-021-05182-6

Table 2.

The effect of different treatments applied in the vineyard on individual phenolic compounds of Feteasca Neagra wines obtained in two vintages representative for the period 2010–2019

Compound (mg L−1) Vintage 2013 Vintage 2014 ANOVA
Org C Org CT Conv C Conv CT Org C Org CT Conv C Conv CT Year (Y) Treatment (T) Yx T
Gallic acid 10.02 ± 2.30a 10.94 ± 2.50a 7.87 ± 1.70a 7.92 ± 1.20a 21.97 ± 2.80c 23.42 ± 2.40c 29.72 ± 3.20b 35.15 ± 2.60a **** ns ****
Syringic acid 1.19 ± 0.23a 1.15 ± 0.25a 1.05 ± 0.27a 1.05 ± 0.22a 3.38 ± 0.8a 3.19 ± 0.60a 3.62 ± 0.90a 2.97 ± 0.201a **** ns ****
p-coumaric acid 2.90 ± 0.70a 3.09 ± 0.90a 3.56 ± 0.74a 3.66 ± 0.60a 1.79 ± 0.30b 2.43 ± 0.51b 3.40 ± 0.30a 3.96 ± 0.60a ns ** **
Catechin 7.43 ± 1.20a 8.23 ± 1.30a 9.63 ± 1.50a 10.17 ± 1.70a 17.63 ± 2.10b 19.47 ± 2.80b 16.54 ± 3.20b 24.47 ± 2.30a **** ns ****
Epicatechin 8.73 ± 1.60b 14.43 ± 2.1a 5.27 ± 1.80c 12.63 ± 2.20a 6.59 ± 1.20c 17.10 ± 2.70a 7.52 ± 1.80c 12.50 ± 2.40b ns **** ****
Rutin 1.68 ± 0.06b 2.06 ± 0.08a 0.12 ± 0.05b 0.24 ± 0.09b 0.33 ± 0.03d 0.77 ± 0.05a 0.49 ± 0.02c 0.68 ± 0.05b ns ** ****
Quercetin 0.13 ± 0.05ab 0.23 ± 0.19a 0.05 ± 0.02b 0.06 ± 0.04b 0.28 ± 0.06a 0.32 ± 0.05a 0.16 ± 0.07b 0.38 ± 0.03a *** * ****
t-resveratrol 0.88 ± 0.03b 1.06 ± 0.09a 0.75 ± 0.05b 1.08 ± 0.10a 1.74 ± 0.09b 2.14 ± 0.10a 1.31 ± 0.07c 1.40 ± 0.06c **** ns ****
De 0.67 ± 0.22b 1.71 ± 0.63a 0.50 ± 0.32b 0.69 ± 0.37b 1.75 ± 0.27b 2.48 ± 0.33a 1.00 ± 0.18c 1.80 ± 0.36b ** ** ****
Cy 0.25 ± 0.11b 0.59 ± 0.26a 0.38 ± 0.10ab 0.40 ± 0.13ab 0.27 ± 0.10a 0.29 ± 0.04a 0.31 ± 0.09a 0.37 ± 0.11a ns ns ns
Pt 0.92 ± 0.55a 1.71 ± 0.38a 1.00 ± 0.30a 1.16 ± 0.52a 4.26 ± 1.172ab 5.93 ± 1.20a 2.16 ± 1.06b 3.90 ± 1.18ab **** ns ****
Pe 0.26 ± 0.11a 0.39 ± 0.22a 0.39 ± 0.22a 0.43 ± 0.15a 3.38 ± 0.52b 4.64 ± 0.66a 2.36 ± 0.30b 5.19 ± 0.76a **** ns ****
Mv 18.91 ± 4.30a 20.73 ± 2.60a 16.08 ± 2.90a 18.94 ± 3.20a 32.75 ± 6.30ab 43.29 ± 7.50a 20.57 ± 6.20a 31.56 ± 5.80ab **** ** ****
Pea 0.35 ± 0.10b 0.35 ± 0.18b 0.82 ± 0.26a 0.74 ± 0.29ab 0.51 ± 0.21a 0.60 ± 0.16a 0.51 ± 0.20a 0.48 ± 0.18a ns ns ns
Mva 5.65 ± 1.62a 6.96 ± 1.35a 0.77 ± 0.28b 0.84 ± 0.33b 1.34 ± 0.30ab 1.78 ± 0.35a 1.04 ± 0.27b 1.25 ± 0.38ab * ns ****
Pec 0.34 ± 0.20a 0.37 ± 0.199a 0.30 ± 0.18a 0.33 ± 0.10a 0.86 ± 0.21ab 1.16 ± 0.32a 0.54 ± 0.16b 0.83 ± 0.20ab **** ns ****
Mvc 2.40 ± 0.30a 1.47 ± 0.10b 1.15 ± 0.10b 1.31 ± 0.16b 1.88 ± 0.33b 2.53 ± 0.38a 1.14 ± 0.27c 1.66 ± 0.29bc ns *** ****

Org–organic system, Conv–conventional system, CT–30% cluster thinning, C–control; Means (n = 3) ± standard deviation followed by different lowercase letters in the line differ significantly according to the Duncan’s multiple range test for year (Y), treatment (T) and both, year and treatment (Y × T): ns: p > 0.05 (not significant), *p ≤ 0.05 (significant), **p ≤ 0.01 (highly significant), ***p ≤ 0.001 (very highly significant) and ****p ≤ 0.0001 (extremely significant)